I listen to the recent presentations and feel that they are very close to landing a partner and advancing the nicotine product. I bought 50K shares this week, have now 90K. Believe we see $4 a share in two years. If they spinout the nicotine product, sharesholders could get a nice extra piece of this new company. I understand this has been a slow process, but that doesn't mean it won't get done. I believe the clearest sign that a deal is about to happen, is the willingness of the group to fund this $6M.
What could a deal look like for ARDM on 3150 ph3 partner. I would guess something like $30M upfront and 20% royality stream after approval. If this is a $1B drug, shareholder could be looking at revenue stream of $200M a year. Not bad for a eleven cent stock. They have something like 18 years of patent protection on this compound. If they netted out $100M a year after expenses, they would have .40 earnings, with a conservative PE of 10, this is a $4 stock.
I just bought more recently one week ago Thurs. at .099 not knowing why but folowing volume increase the weeks before.........looks like I nailed it doubling down on a lighter 25K shs from .16 which is where we are now. Wish I bought more.............
Glad to see that it's working out. The dilution is not so bad, since the parties getting those shares, will probably hold on long term. They will have near $40M after this is over. I would like to see them reign in some expenses. This looks like they will have 2.5 years of funding. Plentity to get some additional projects off the ground. This also sounded like ard-3100 will also get some attention by the partner.